Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Understand all you are saying. I was referencing total dollar amount of Novacure when they reached over 200 putting them at 20B plus for a technology that is not widely used and will never be the story that NWBO will be if the technology turns out to be what we all believe it will be. Storied stocks have completely different market valuations.
Please explain the valuation of Novacure when it was reaching over 200 dollars with a device that is barely used. I think you need to look a lot more into the science because as LP has said for many years DCVAX is a platform technology. Your valuation is poor and I hope not too many longs with good knowledge will be fooled into believing that this technology will only be worth up to 7B over the next 2 to 4 years. When the world realizes how quickly L will be recognized as a platform technology and also realize the potential of D well you tell me what happens then. We are talking a paradigm shift in how all cancers are treated.
Deepest condolences to you and your family. The loss of a loved one never leaves you and their brightest memories live with you forever. May the comfort of those memories help you and your family through this painful period and here’s to hoping that DCVax helps prevent such tragedies in the near future.
Holding back the Kraken will not last. When the world awakens to Dendritic Cell tech that will make magical inroads against cancers and then branch into all kinds of diseases there will be no stopping this beast. We are sick and tired of chemicals wreaking havoc on our bodies and it is now time for our natural immune systems to be radically transformed through our ingenuity to target all alien forces that target our bodies. NWBO and it’s tech will transform medicine as we know it. I just don’t think current BP’s know or are ready for the transformation. LP knows what she has and has always spoken about platform technology. The powers to be tried to destroy NWBO and they failed, the time of dendritic cell tech is upon us. Release the Kraken.
Flip, would it be at all possible to determine the idh type of the long term survivors that came out of these trials. There will be so few of them so I would think it would be possible to determine if they were true GBM or not. My thinking is a lot of data would have been gathered from these long term survivors to try and determine Why.
Price suppression and accumulation.
Almost as if he is now in cahoots with a cabal who want to initiate price suppression after TLD to $5 in order to accumulate vast quantities from Longs before the uplist. Looks like they know that current price suppression is not dislodging enough shares so a new target is being set. We know that institutions will eventually hold the majority and it all depends at what price retail are willing to cash in. I believe that longs know the value and $5 will not hold as news of a potential paradigm shift hit the airwaves.
Unfortunately for you Ex, the SAP was created before the unblind, “a priori” from a research perspective means knowledge that comes before the facts so yes they did create an SAP based on all the knowledge they had before the unblind so using external controls will not be an issue.
Par for course for the doubters to try and setup real investors to sell early into any news to allow not only covering but attainment of retail shares. To put it simply the tactic is to suppress share price for a long period of time and hope that retail investors will give up their shares at the first sense of real profit. We will hear many low balled estimates from the doubters who are not willing to risk money leading into top line but will no doubt be willing to capitalize on retail sellout if their tactics work out. In this case they may be surprised because most long term shareholders know what they hold.
So by your assumption the company is in cahoots with the market makers and have provided them with their timelines. There is no way a chart can predict the future unless their is a massive fix and we are all victims. So by your logic and even with a fully functioning manufacturing facility we will not go above 1.40, a pessimistic outlook indeed.
LP has always viewed L and D as platform technologies and once L is approved in the hardest to treat cancer the gloves are off and she will be shooting for a valuation no less than 50 Billion which would still be cheap. The challenge will be reaching a minimum of $20 out the gate which I think can be achieved with the plan that seems to be coming together. If we reach that target and Merck is blown away by the results of the UCLA trial my thinking is LP will be shooting for that minimum of $50. Good luck to all.
Happy New Year to you all and wishing upon a beautiful year where NWBO is revealed to the world and hope for all those afflicted with such a deadly disease becomes a reality.
Another thing you may not like, dendritic cell style vaccines won't stop at cancer. There's a whole lot of hurt out there where our immune systems with a little education can fulfill their true potential.
I agree with Flip. What you fail to understand is that Flaskworks creation was already underway when Cognate was sold off. LP knows where the real future lies in this manufacturing space. I fully expect NWBO to completely control future production of dendritic cells. This obviously is not something you and your ilk would like.
COVID has made any time constraint laws irrelevant. Not sure why you insist on holding your ground here. We now live in a time where Covid is an easy excuse.
BSB is asking for you to present the list you so kindly share regarding total NWBO OS.
Well said and I believe the real reward will come well after top line. Retail have always cashed in their chips to early and given away what for many could be a legacy investment if their patience and belief extend beyond the baby and toddler years. Vision is required here and it is in abundance within the 4 walls of NWBO. Choosing to buy into that vision will determine if some on this board achieve a lifelong legacy for their loved ones or a brief utopia that evaporates all too soon.
Maybe just maybe a contract between NWBO and Cognate/CRL is not required at this point. I say this because NWBO has gone into a self imposed quiet period and it looks like they are proving that they will have capacity to start manufacturing very shortly in the UK albeit for specials only at this point. More importantly I believe work is also being concurrently advanced with Flaskworks per recent posts by iwasadiver. The companies goals have certainly changed since they acquired Flaskworks and they must believe this is the way forward.
When DCVAX-L meets full approval here in the US sometime after topline and publication I believe they will be in a better position to assess how they meet demand, and if they do indeed need CRL will renegotiate at that point.
We also have the outlier that may still be in play and that is a partner is waiting in the wings for NWBO to reach a number of set goals before they step in, some of these goals may involve Sawston/Flaskworks/Publication/TLD etc. Flipper has outlined many of these goals and events within the oncology space that have been highlighting the growing importance that a new paradigm to treat GBM is revealed in short order. JMHO.
Manipulation as they bought literally millions in the low 20’s so they can run this all the way down if they want. We spent years in the doldrums and now that we are back in penny land this can be sunk fast as they have a ton in the money to bring this down. Looks like a concerted effort by the hedge funds to make there money back by attacking the OTC. JANE only recently appeared in the last 6 months and their appearance had coincided with a meltdown of many of the stocks they are currently trading. JMO
The only issue is Dan that they now have this back into penny land and they will relentlessly pound this down if there is no support. There are gangs that operate the OTC boards that will continually work this down to their next short position which could be 50c. They have succeeded in getting it down this low and probably covered. With nothing from the company they will continue to pound this back down into the dirt where they enjoy 40 to 100% swings on pennies.
Silence from NWBO is killing the SP and shareholders gains will be wiped out in no time by the thugs that operate on these boards.
Disappointment from no show SNO and stupid bag theories will only serve to cause many more positions being closed due to the fear that represents the SP being taken down to the 20's and 30's especially if we have silence going into the new year.
If we do not see a rally over the coming days the SP is dead in the water.
It seems like the nail gets deeper with each passing month. The final strike will be sudden and the constant gabble from our detractors will produce a graveyard of silence.
Appreciate the feedback.
So next support line looks like 30 cents. How long before we get there. If we are still months out from publication then it looks like they will take it down further.
Hi iwasadiver, I just need to get some reassurances with respect the use of Remdesivir even though Ebola studies have proven it to be ineffective as it can possible cause kidney malfunction etc which seems to be an underlying cause of death amongst those being treated for Covid in hospitals currently.
I would also like to add a very important document for your perusal from the FDA website from October 22 2020 in relation to Covid 19 vaccines and their side effects which are as follows.
Remember these side effects were listed for the meeting before the rollout of the vaccines.
FDA Safety Surveillance of COVID-19 Vaccines :
DRAFT Working list of possible adverse event outcomes
***Subject to change***
? Guillain-Barré syndrome
? Acute disseminated encephalomyelitis
? Transverse myelitis
? Encephalitis/myelitis/encephalomyelitis/
meningoencephalitis/meningitis/
encepholapathy
? Convulsions/seizures
? Stroke
? Narcolepsy and cataplexy
? Anaphylaxis
? Acute myocardial infarction
? Myocarditis/pericarditis
? Autoimmune disease
? Deaths
? Pregnancy and birth outcomes
? Other acute demyelinating diseases
? Non-anaphylactic allergic reactions
? Thrombocytopenia
? Disseminated intravascular coagulation
? Venous thromboembolism
? Arthritis and arthralgia/joint pain
? Kawasaki disease
? Multisystem Inflammatory Syndrome
in Children
? Vaccine enhanced disease
This list is alarming and the public are not being informed. Most alarming is the Multisystem Inflammatory Syndrome in Children and it seems that the Government is now hellbent in vaccinating all children.
Your insights would be most appreciated if you have time.
Here is the link.
https://www.fda.gov/media/143557/download
Blind trust in authority is the greatest enemy of truth. Albert Einstein.
A beautiful dawn is fast approaching when news of the future of cancer therapy though immunotherapy will provide people across this world real hope that finally science is making inroads into defeating this devastating disease that has afflicted so many loved ones across the ages.
You do not have to pay taxes on earnings in a Roth IRA. If you have your shares in any other type of account before TLD then prepare to pay massive amounts to the Government for many years to come.
There is a simple strategy behind the takedown or indeed low price per share before the ground breaking news that is about to hit the airwaves. The low price per share creates doubt and anxiety amongst retail eager to see their portfolios grow. What will happen here as has been seen countless times in the past is when news breaks those beaten down retail shareholders will be the first to sell because the psychology practiced means as soon as they see a number they are comfortable with they will sell and those shares will go to those who know the true value. What we have here is a paradigm shift and for all longs who truly understand the shift in oncology I say this, have a quick look at the history of a company such as TSLA and you will see growth of 21000 odd %. You are invested in a company that will have similar returns if indeed DCVAX L and D are to become SOC. Look long and hard at how patient you have been on your wait for news and make sure you do not pull the trigger to quickly when the news hits the airwaves. The more tightly shares are held because of the combined retail knowledge of value the quicker we will see the Market valuing the company how it should be. Keep it real and don’t cave in to the antics of the MM’s and their entourage who would love to steal your investment at low low prices.
As always you cut right to the point.
Quote:
AMAZINGLY, DARK, LONG & WINDING TORTUROUS journey nearing a Foggy sunrise?
For many PRE 2018 NWBO investors it has been a nightmare.
What we have also learnt is extreme patience, perseverance, tenacity, endurance and a collective belief in the beauty of the science that is the Phoenix about to rise from the ashes of its long and tortuous journey.
So what you are saying is it is all fixed and the MM’s have been informed by NWBO when TLD will be shared so go ahead and set your algo’s for July/Aug next year. Are you serious because if you are you are telling everyone that the market is so rigged that even small bios like NWBO are in on the scam. Can you let me know how I can be part of this email because I could make a mint before top line truly comes out.
Would you accept a sealed bid on a paradigm shift that potentially is SOC for both operable and inoperable cancers. Chemical treatment to immunotherapy is the shift, so c'mon give me your sealed bid for the technology that could change the way people treat cancers.
Hi Sojo, thanks for giving me an education on the workings of charts which have spiked my own interest in looking more into the subject. Although many of us will miss your daily analysis it sounds like you will continue to banter on this board which I am sure will be just as welcome.
There have been 40+ million exercised in the last month alone which means an additional 10+ million for NWBO. It looks like since Biggars convo with NWBO he may have been exercizing a bunch more and NWBO should have enough in the coffers to take this to launch which is hopefully soon.
Well it does look interesting with a jump up to 921,053,016. No issue with paying off any loans with that exercise. I too think that we are close and if NWBO is part of Project Orbis in the UK the MHRA inspection may hold a lot more than everyone is expecting. With most warrant holders in an exercised position we can expect massive volume when news hits.
Another fact is that all those warrant holders now hold their shares and are ready to benefit from an explosion of news that will obviously allow them to benefit after so many years of supporting this company. The type of volume we have been seeing for months does not indicate a mass sell off by warrant holders but does show that traders have been playing a cycle of 20 to 40% very effectively, which is very common on the OTC. Scaremongering by the few regarding the exercising which let’s face it have allowed the company to get their proverbial ducks in a row is just noise and at some point a great deal of covering will take place. How much, who knows, but know this, if the results are half as good as we expect this becomes a storied stock and millions will want to jump on the bandwagon. When that happens we will see 100 million plus days. Make sure you are ready to strike to take advantage at this time as I am sure many on here are. We wait patiently knowing that any point the cancer paradigm will be shifted.
You were talking up your DD and conversation with DI you shared with this board. No where in that conversation you shared did you make an opinion of 2022, in fact subsequent posts from you implied that you will pull out of your investment if you see nothing by the end of October. Talking to NWBO at this point would be pointless DD due to their self imposed quiet period.
Can you confirm that even though NWBO is in a self imposed quiet period DI gave you hard evidence that TLD will not be released until Q1 2022. Is this fact or just a perception which is not fact.
Fully understand the scale this has on the oncology space and why you are so impressed. Looking forward to an exciting few months as more and more is revealed. It is no wonder Dr Stupp was stumbling a number of times in his interview, almost as if he knew back in May that there is no stopping this train so he decided unwillingly it seems to climb aboard.
What is really interesting is that from the May 22nd interview we saw a flash climb of Novacure to it's high and then the inevitable selloff. Could this interview have been a market signal that a novel new approach is about to hit the airwaves signaling the end of the helmut and the downgrading of Novacure.
As I have said the statement is highly positive for shareholders.